Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 20 Feb 2026
A study on the prevalence and correlates of high-sensitivity C-reactive protein ≥2 mg/L. across the spectrum of HF using date from 3 major trials: SELECT, SOUL, and FLOW.
Read Full NewsEli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed better results in patients with the skin disease and obesity in a...
Patients with moderate‑to‑severe plaque psoriasis achieve greater relief from itching, skin pain, and scaling with bimekizumab vs secukinumab up to 3 years.
Treatment with amivantamab is associated with a broad spectrum of dermatologic adverse events that can be severe in patients with non-small cell lung cancer, a real-world study shows.
South Carolina reported a surge to 962 measles cases on Tuesday, state health data showed, including 12 additional infections since Friday, as officials warned the widening...
As currently written, the instructions could potentially lead to delayed treatment of high glucose levels.
An expansion of higher-level neonatal care has been observed in urban hospitals in the US over the years, whereas rural hospitals have faced a decline in such care capacity, per a recent study.
1.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
2.
Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.
3.
For treatment, the majority of cancer patients choose complementary therapies.
4.
Study reveals that older women frequently receive an incorrect breast cancer diagnosis.
5.
AI Model as Effective as Radiologists in Detecting Prostate Cancer on MRI
1.
The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment
2.
Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment
3.
Multimodal Data Fusion with Deep Neural Networks - Revolutionizing Oncology with Precision Cancer Diagnosis 2025
4.
The Benefits and Risks of Transurethral Resection of Bladder Tumor
5.
The New Era of Oncology: Key Updates and Clinical Insights
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
5.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge